Pidotimod
From Wikipedia, the free encyclopedia
Systematic (IUPAC) name | |
---|---|
(4R)-3-(5-oxo-L-prolyl)-1,3-thiazolidine-4-carboxylic acid | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status | ? |
Identifiers | |
ATC code | L03AX05 |
PubChem | CID 65944 |
ChemSpider | 59348 |
UNII | 785363R681 |
KEGG | D07261 |
ChEMBL | CHEMBL1488165 |
Synonyms | (4R)-3-[(2S)-5-oxopyrrolidine-2-carbonyl]-1,3-thiazolidine-4-carboxylic acid |
Chemical data | |
Formula | C9H12N2O4S |
Mol. mass | 244.26758 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Pidotimod is an immunostimulant.[1]
References
- ↑ Du XF, Jiang CZ, Wu CF, Won EK, Choung SY (September 2008). "Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression". Archives of pharmacal research 31 (9): 1153–9. doi:10.1007/s12272-001-1282-6. PMID 18806958.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.